†rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

ACCOUNTSPARENT COMPANY PROFIT AND LOSS STATEMENTNote 2000 1998/99(000)DKK(000)DKK7 monthsGROSS PROFIT 0 01 Administration expenses - 15,987 - 6,537OPERATING PROFIT - 15,987 - 6,5374 Share of result before tax in subsidiaries 5,032 - 19,0682 Financial income 2,443 2,3972 Financial expenses - 48,966 - 31,422RESULT BEFORE TAX - 57,478 - 54,6303 Income tax expenses 14,268 - 2,439NET RESULT - 43,210 - 57,069–54–